Clinical Trial

Validate the Temporal Stability and Responsiveness of AI-COA® for Depression and Anxiety

Study acronym: SEQUOIA-2
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
This study evaluates the reliability and responsiveness of the AI-COA®, a digital tool designed to assess the severity of depression and anxiety. The study compares the tool's performance against standard clinician ratings over 12 weeks to determine its consistency and sensitivity to symptom changes.
Trial Details
NCT Number NCT07279025
Lead Sponsor Deliberate Solutions Inc.
Collaborators: Baylor College of Medicine, National Institute of Mental Health (NIMH)
Conditions Depression Disorders, Anxiety Disorders
Enrollment 150 participants
Start Date 2026-03-01
Primary Completion 2027-02-28 (estimated)
Study Completion 2027-02-28 (estimated)
Updated on ClinicalTrials.gov 2025-12-12